Gene therapy developer gets chance at a comeback with Pfizer deal
Bio Pharma Dive
OCTOBER 6, 2021
Voyager Therapeutics recently scrapped much of its pipeline and replaced top executives. Now, a Pfizer deal on new technology gives investors hope.
Bio Pharma Dive
OCTOBER 6, 2021
Voyager Therapeutics recently scrapped much of its pipeline and replaced top executives. Now, a Pfizer deal on new technology gives investors hope.
World of DTC Marketing
OCTOBER 6, 2021
SUMMARY: Via Axios – The antiviral pill that showed promising results against severe COVID-19 was initially developed at Emory University with $35 million of taxpayer grants. And while it costs $17.74 to produce, according to a report issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 6, 2021
The drugmaker suspended dosing in two mid-stage studies of its experimental narcolepsy treatment after a "safety signal" emerged.
Pharma Mirror
OCTOBER 6, 2021
Limerick, Ireland: Irish SFI-funded research centre SSPC has announced a major collaboration with five of the world’s leading BioPharma companies that aims to reduce waste, maintain standards and minimise costs in pharmaceutical processes. The rising need for early diagnosis of chronic diseases, coupled with growing demand for drugs which work better and have fewer side effects, is largely responsible for the growth of the protein A resin market.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Bio Pharma Dive
OCTOBER 6, 2021
The neuroscience-focused biotech continues to win market share in a battle with some of the industry's largest companies.
Pharma Mirror
OCTOBER 6, 2021
Abu Dhabi, UAE – Etihad Cargo, the cargo and logistics arm of Abu Dhabi’s Etihad AviationGroup, has expanded its pharma sector reach into Africa with the signing of a Service LegalAgreement (SLA) with Astral Aviation and Kenya Airways to provide reliable and cost-effective airfreight solutions across the continent.Operating a fleet of 14 freighters out of its Nairobi and Johannesburg hub, Astral Aviationservices a network of 15 African destinations, which Etihad Cargo will leverage for increased
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Mirror
OCTOBER 6, 2021
Abu Dhabi, UAE – Etihad Cargo, the cargo and logistics arm of Abu Dhabi’s Etihad AviationGroup, has expanded its pharma sector reach into Africa with the signing of a Service LegalAgreement (SLA) with Astral Aviation and Kenya Airways to provide reliable and cost-effective airfreight solutions across the continent.Operating a fleet of 14 freighters out of its Nairobi and Johannesburg hub, Astral Aviationservices a network of 15 African destinations, which Etihad Cargo will leverage for increased
Pharma Times
OCTOBER 6, 2021
UK-based Scancell Holdings has announced that its first subject has been dosed in its COVIDITY clinical trial in South Africa.
pharmaphorum
OCTOBER 6, 2021
Voyager Therapeutics has just landed a new gene therapy alliance with Pfizer that could go some way towards easing the pain of losing three other partners in the space of a couple of years. Pfizer is paying Voyager $30 million upfront to get access to its TRACER adeno-associated virus (AAV) vector technology, which aims to improve the safety of gene therapies – a field that has suffered a string of safety scares in the last few months.
Pharma Marketing Network
OCTOBER 6, 2021
By: Marc Guldimann, Co-founder and CEO, Adelaide. Targeting and attribution challenges are universal, but pharmaceutical advertisers encounter several unique hurdles with digital advertising. Given their often niche content, pharma marketers must target smaller, more exclusive audiences to drive results while developing impactful creative. Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of thir
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
pharmaphorum
OCTOBER 6, 2021
Digital health tools hold huge potential, and the evidence base is growing all the time – so what is holding us back and how does the sector overcome the multiple barriers to widespread adoption? We are living through a digital health revolution, and the pace of change has been accelerated by the COVID-19 pandemic. More than 90,000 health-related mobile apps were released onto the market in 2020 alone, according to an IQVIA Institute report , that’s an average of 250-plus every day.
XTalks
OCTOBER 6, 2021
Do Good Foods, a meat startup that uses surplus groceries to make animal feed for its chickens, is set to roll out its first product line, Do Good Chicken , in the new year. After securing a $169 million investment from asset-management giant Nuveen, the startup used the funds to build a production facility in Pennsylvania capable of processing 160 tons of surplus food daily. .
Cloudbyz
OCTOBER 6, 2021
Cloudbyz brings to you a 60 minutes virtual knowledge sharing session on Pharmacovigilance: Digital Transformation Leveraging Salesforce. Date & Time: 12th October @ 12 pm EDT/ 9 am PDT. Agenda: Cloudbyz intends to deliver a comprehensive overview on the Digital Transformation of “Pharmacovigilance Leveraging Salesforce” and would broadly cover the following discussion points: 1.
pharmaphorum
OCTOBER 6, 2021
Exscientia’s artificial intelligence-based drug discovery engine is still largely unproven, but that hasn’t stopped the company raking in funding from investors keen to back its platform. The final numbers are now in from its recently announced initial public offering on the US Nasdaq, and the numbers are impressive, swelling from an initially forecast $304 million to just over $350 million.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
OCTOBER 6, 2021
Flakes of paint could be one of the most abundant type of microplastic particles in the ocean, new research has suggested. Credit: Andrew Turner, University of Plymouth Flakes of paint could be one of the most abundant type of microplastic particles in the ocean, new research has suggested. Through a range of surveys conducted across […].
BioSpace
OCTOBER 6, 2021
GlaxoSmithKline shares jumped in aftermarket trading Wednesday after the WHO recommended broad deployment of the company’s malaria vaccine in sub-Saharan Africa and other areas.
Scienmag
OCTOBER 6, 2021
Los Alamos, N.M., Oct. 6, 2021—A new data source to help scientists better understand the ionosphere and its potential impact on communications and positioning, navigation, and timing—an essential utility for many critical operations—is now available to the public. The data, which was collected by sensors on GPS satellites in 2018, was released todaythrough a collaborative effort […].
BioSpace
OCTOBER 6, 2021
Fresh out of the gates with $500 million in financing, Neumora Therapeutics forged a partnership with Amgen to develop and commercialize assets for neurodegenerative diseases.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
OCTOBER 6, 2021
SASKATOON – Researchers at the University of Saskatchewan (USask) are hopeful new understanding of cellular defects related to Cystic Fibrosis (CF) could help pave the way for treatment of the disease. Credit: Canadian Light Source SASKATOON – Researchers at the University of Saskatchewan (USask) are hopeful new understanding of cellular defects related to Cystic Fibrosis […].
BioSpace
OCTOBER 6, 2021
Denali Therapeutics reported positive Phase I data and regulatory progress for two therapeutics for ALS at the virtual 2021 Annual Northeast ALS Meeting.
Scienmag
OCTOBER 6, 2021
Philadelphia, October 7, 2021 – Looking beyond the picky eating of childhood, researchers looked at this behavior in college students. Self-identified picky eaters ate significantly less fiber and vegetables and reported greater levels of social phobia than non-picky eaters, according to a new study in the Journal of Nutrition Education and Behavior, published by Elsevier. […].
pharmaphorum
OCTOBER 6, 2021
So much effort goes into ensuring the successful launch of a new pharmaceutical product or indication, but it’s only once that has been achieved that the real work begins, says Align Strategy’s Christine Fletcher. Introducing a new pharmaceutical brand is akin to asking someone to change their established habits, and first impressions of that treatment once it hits the market, is the crucial factor for determining whether new preferences will be adopted.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
OCTOBER 6, 2021
Although strokes can occur no matter how old you are, your risk for one increases as you age. About two-thirds of the people hospitalized for one are at least 65 years old, according to the Centers for Disease Control. Yet historically, most stroke studies involving animal models have focused on young test subjects, not older […].
BioPharma Reporter
OCTOBER 6, 2021
Absci Corp, a synthetic biology firm, is partnering with pharma company, EQRx, to jointly engineer and develop several clinical candidates across multiple therapeutic areas, including oncology and immunology.
Scienmag
OCTOBER 6, 2021
Many elementary education majors graduate from teacher preparation programs with incomplete knowledge of science content and limited experience with teaching science in ways that are proven to be effective for elementary students. Credit: Northern Arizona University Many elementary education majors graduate from teacher preparation programs with incomplete knowledge of science content and limited experience with […].
BioSpace
OCTOBER 6, 2021
Intergalactic Therapeutics closed on a Series A funding round worth $75 million. The company was launched by Advanced Technology Products Corporation (ATP).
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Scienmag
OCTOBER 6, 2021
Usually, the electrical resistance of a material depends very much on its physical dimensions and fundamental properties. Under special circumstances, however, this resistance can adopt a fixed value that is independent of the basic material properties and “quantised” (meaning that it changes in discrete steps rather than continuously). This quantisation of electrical resistance normally occurs […].
BioSpace
OCTOBER 6, 2021
The patch is not only painless, it requires less vaccine to generate the same or greater effects.
Scienmag
OCTOBER 6, 2021
A culturally grounded, community approach to improving the health of Latino youth at risk for Type 2 diabetes is expanding to include entire families. Credit: Photo from 2019 by Deanna Dent/ASU News A culturally grounded, community approach to improving the health of Latino youth at risk for Type 2 diabetes is expanding to include entire […].
BioSpace
OCTOBER 6, 2021
Let’s talk about some of the most common mistakes job candidates make during interviews, so you can steer clear of them for your next interview!
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Let's personalize your content